Ratings by JPMorgan (Tycho Peterson)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/27/2024 | Sotera Health | SHC | Maintain | Neutral (N/A) |
|
Details | ||
| 2/8/2024 | Qiagen NV | QGEN | Maintain | Overweight (N/A) |
|
Details | ||
| 12/20/2023 | Agilent | A | Maintain | Overweight (N/A) |
|
Details | ||
| 12/19/2023 | Qiagen NV | QGEN | Maintain | Overweight (N/A) |
|
Details | ||
| 11/17/2023 | Laboratory Corporation of America | LH | Maintain | Overweight (N/A) |
|
Details | ||
| 11/8/2023 | OraSure Technologies | OSUR | Maintain | Neutral (N/A) |
|
Details | ||
| 11/2/2023 | DENTSPLY SIRONA | XRAY | Maintain | Neutral (N/A) |
|
Details | ||
| 11/2/2023 | Envista Holdings Corp. | NVST | Maintain | Overweight (N/A) |
|
Details | ||
| 10/17/2023 | Qiagen NV | QGEN | Maintain | Overweight (N/A) |
|
Details | ||
| 8/16/2023 | Agilent | A | Maintain | Overweight (N/A) |
|
Details | ||
| 8/3/2023 | Envista Holdings Corp. | NVST | Maintain | Overweight (N/A) |
|
Details | ||
| 5/24/2023 | Agilent | A | Maintain | Overweight (N/A) |
|
Details | ||
| 5/9/2023 | Akoya Biosciences Inc | AKYA | Maintain | Overweight (N/A) |
|
Details | ||
| 5/4/2023 | Envista Holdings Corp. | NVST | Maintain | Overweight (N/A) |
|
Details | ||
| 5/4/2023 | 10X Genomics | TXG | Maintain | Overweight (N/A) |
|
Details | ||
| 4/26/2023 | Laboratory Corporation of America | LH | Maintain | Overweight (N/A) |
|
Details | ||
| 4/26/2023 | Illumina | ILMN | Maintain | Neutral (N/A) |
|
Details | ||
| 3/1/2023 | Sotera Health | SHC | Maintain | Neutral (N/A) |
|
Details | ||
| 2/28/2023 | DENTSPLY SIRONA | XRAY | Maintain | Neutral (N/A) |
|
Details | ||
| 2/21/2023 | Laboratory Corporation of America | LH | Maintain | Overweight (N/A) |
|
Details | ||
| 2/17/2023 | 10X Genomics | TXG | Maintain | Overweight (N/A) |
|
Details | ||
| 2/8/2023 | Illumina | ILMN | Maintain | Neutral (N/A) |
|
Details | ||
| 1/23/2023 | Sotera Health | SHC | Upgrade | Neutral (Underweight) |
16.82 (11.32) |
-32.7% | Details | |
| 11/9/2022 | Seer Inc. | SEER | Maintain | Neutral (N/A) |
|
Details | ||
| 11/4/2022 | Mettler-Toledo | MTD | Maintain | Underweight (N/A) |
|
Details | ||
| 11/4/2022 | Envista Holdings Corp. | NVST | Maintain | Overweight (N/A) |
|
Details | ||
| 11/3/2022 | Sotera Health | SHC | Maintain | Underweight (N/A) |
|
Details | ||
| 10/28/2022 | Laboratory Corporation of America | LH | Maintain | Overweight (N/A) |
|
Details | ||
| 9/21/2022 | Sotera Health | SHC | Downgrade | Underweight (Overweight) |
9.83 (16.82) |
71.11% | Details | |
| 8/12/2022 | Absci Corp. | ABSI | Downgrade | Underweight (Overweight) |
4.79 (4.46) |
-6.89% | Details | |
| 8/12/2022 | Illumina | ILMN | Maintain | Neutral (N/A) |
|
Details | ||
| 8/11/2022 | Seer Inc. | SEER | Downgrade | Neutral (Overweight) |
10.27 (1.75) |
-82.96% | Details | |
| 8/10/2022 | Berkeley Lights | BLI | Downgrade | Neutral (Overweight) |
5.18 (1.20) |
-76.83% | Details | |
| 7/26/2022 | Zymergen Inc | ZY | Upgrade | Neutral (Underweight) |
2.32 (2.43) |
4.74% | Details | |
| 5/11/2022 | DENTSPLY SIRONA | XRAY | Maintain | Neutral (N/A) |
|
Details | ||
| 5/5/2022 | Pacific Biosciences of California | PACB | Maintain | Overweight (N/A) |
|
Details | ||
| 5/5/2022 | 10X Genomics | TXG | Maintain | Overweight (N/A) |
|
Details | ||
| 3/15/2022 | Akoya Biosciences Inc | AKYA | Maintain | Overweight (N/A) |
|
Details | ||
| 3/1/2022 | Seer Inc. | SEER | Maintain | Overweight (N/A) |
|
Details | ||
| 2/28/2022 | DENTSPLY SIRONA | XRAY | Maintain | Neutral (N/A) |
|
Details | ||
| 2/16/2022 | Adeptus Biotechnologies Corp. | ADPT | Maintain | Overweight (N/A) |
|
Details | ||
| 10/28/2021 | Laboratory Corporation of America | LH | Maintain | Overweight (N/A) |
|
Details | ||
| 9/27/2021 | Talis Biomedical Corp. | TLIS | Downgrade | Underweight (Neutral) |
7.30 (9.00) |
23.29% | Details | |
| 9/27/2021 | Zymergen Inc | ZY | Downgrade | Underweight (Neutral) |
13.80 (2.32) |
-83.19% | Details | |
| 9/8/2021 | Absci Corp. | ABSI | Maintain | Overweight (N/A) |
|
Details | ||
| 8/11/2021 | Talis Biomedical Corp. | TLIS | Downgrade | Neutral (Overweight) |
8.97 (9.00) |
0.33% | Details | |
| 8/5/2021 | Ortho Clinical Diagnostics | OCDX | Maintain | Overweight (N/A) |
|
Details | ||
| 8/5/2021 | 10X Genomics | TXG | Maintain | Overweight (N/A) |
|
Details | ||
| 8/4/2021 | Zymergen Inc | ZY | Downgrade | Neutral (Overweight) |
34.03 (2.43) |
-92.86% | Details | |
| 5/26/2021 | Agilent | A | Maintain | Overweight (N/A) |
|
Details | ||
| 5/11/2021 | Akoya Biosciences Inc | AKYA | New Coverage | Overweight (N/A) |
19.75 (3.82) |
-80.66% | Details | |
| 5/6/2021 | Envista Holdings Corp. | NVST | Maintain | Overweight (N/A) |
|
Details | ||
| 3/9/2021 | Talis Biomedical Corp. | TLIS | New Coverage | Overweight (N/A) |
14.65 (9.00) |
-38.57% | Details | |
| 2/22/2021 | Ortho Clinical Diagnostics | OCDX | New Coverage | Overweight (N/A) |
16.98 (17.63) |
3.83% | Details | |
| 12/29/2020 | Seer Inc. | SEER | New Coverage | Overweight (N/A) |
62.04 (1.75) |
-97.18% | Details | |
| 12/15/2020 | Sotera Health | SHC | New Coverage | Overweight (N/A) |
25.41 (11.32) |
-55.45% | Details | |
| 11/24/2020 | Agilent | A | Maintain | Overweight (N/A) |
|
Details | ||
| 10/2/2020 | Pacific Biosciences of California | PACB | Upgrade | Overweight (Neutral) |
9.87 (1.38) |
-86.02% | Details | |
| 9/28/2020 | Mettler-Toledo | MTD | Downgrade | Underweight (Neutral) |
960.26 (1232.91) |
28.39% | Details | |
| 9/21/2020 | Illumina | ILMN | Downgrade | Neutral (Overweight) |
295.50 (121.05) |
-59.04% | Details | |
| 9/8/2020 | GenMark Diagnostics | GNMK | Maintain | Neutral (N/A) |
|
Details | ||
| 8/20/2020 | Qiagen NV | QGEN | New Coverage | Overweight (N/A) |
52.21 (41.08) |
-21.32% | Details | |
| 8/11/2020 | Berkeley Lights | BLI | New Coverage | Overweight (N/A) |
57.55 (1.20) |
-97.91% | Details | |
| 8/10/2020 | OraSure Technologies | OSUR | New Coverage | Neutral (N/A) |
13.09 (5.26) |
-59.82% | Details | |
| 7/28/2020 | Waters Corp. | WAT | Upgrade | Neutral (Underweight) |
227.45 (308.35) |
35.57% | Details | |
| 5/12/2020 | Quidel Corp. | QDEL | Downgrade | Underweight (Neutral) |
158.60 (97.25) |
-38.68% | Details | |
| 5/7/2020 | Natera | NTRA | Upgrade | Overweight (Neutral) |
36.31 (91.28) |
151.39% | Details | |
| 3/2/2020 | PPD Inc. | PPD | New Coverage | Overweight (N/A) |
35.18 (47.30) |
34.45% | Details | |
| 12/11/2019 | GenMark Diagnostics | GNMK | Downgrade | Neutral (Overweight) |
5.62 (24.04) |
327.76% | Details | |
| 12/11/2019 | DENTSPLY International | XRAY | Downgrade | Neutral (Overweight) |
57.32 (30.35) |
-47.05% | Details | |
| 11/14/2019 | Qiagen NV | QGEN | Upgrade | Overweight (Underweight) |
32.26 (41.08) |
27.34% | Details | |
| 10/14/2019 | Envista Holdings Corp. | NVST | New Coverage | Overweight (N/A) |
29.07 (20.02) |
-31.13% | Details | |
| 10/8/2019 | Qiagen NV | QGEN | Downgrade | Underweight (Neutral) |
32.35 (41.08) |
26.99% | Details | |
| 10/7/2019 | 10X Genomics | TXG | New Coverage | Overweight (N/A) |
48.12 (26.90) |
-44.1% | Details | |
| 9/27/2019 | Accelerate Diagnostics | AXDX | Downgrade | Underweight (Neutral) |
21.12 (0.95) |
-95.5% | Details | |
| 9/27/2019 | Luminex | LMNX | Downgrade | Underweight (Neutral) |
21.80 (32.95) |
51.15% | Details | |
| 7/29/2019 | Genomic Health Inc. | GHDX | Upgrade | Neutral (Underweight) |
68.66 (63.44) |
-7.6% | Details | |
| 12/12/2018 | Waters Corp. | WAT | Downgrade | Underweight (Neutral) |
189.54 (227.45) |
20% | Details | |
| 11/26/2018 | Twist Bioscience | TWST | New Coverage | Neutral (N/A) |
25.45 (31.08) |
22.12% | Details | |
| 11/7/2018 | Accelerate Diagnostics | AXDX | Downgrade | Neutral (Overweight) |
16.01 (21.12) |
31.92% | Details | |
| 10/5/2018 | Natera | NTRA | New Coverage | Neutral (N/A) |
24.17 (91.28) |
277.66% | Details |
